Showing results (61-70 of 628) with videos related to

Sort By:
Pageof 63
Digestion|January 1, 1982
Inhibition of pentagastrin-stimulated gastric acid secretion by upper intestinal hyperosmolality in chronic gastric fistula ratsM Mogard, S Emås, G Nylander, et al.
Histology and Histopathology|April 1, 1993
Gastric intestinal metaplasia eleven years after randomized selective proximal vagotomy for peptic ulcerC A Rubio, S Emås, P Slezak, et al.
Regulatory Peptides|July 14, 1994
Transforming growth factor-alpha and epidermal growth factor inhibit gastric acid secretion and stimulate release of somatostatin and neurotensin in the conscious ratG Grupcev, C Wallin, S Emås, et al.
Alcoholism, Clinical and Experimental Research|October 6, 1997
Drug and alcohol use among injured motor vehicle drivers in Sweden: prevalence, driver, crash, and injury characteristicsH Sjögren, U Björnstig, A Eriksson, et al.
International Journal of Immunopharmacology|January 1, 1989
Oral treatment with RU 41.740 (Biostim) in patients with advanced colorectal cancer: influence on the blood lymphocyte populationH Blomgren, H Viland, B Cedermark, et al.
Scandinavian Journal of Gastroenterology|June 1, 1988
Comparison of gastric aspiration and HIDA scintigraphy in detecting fasting duodenogastric bile refluxB Eriksson, S Emås, H Jacobsson, et al.
Acta Physiologica Scandinavica|June 1, 1995
Release of somatostatin, neurotensin and vasoactive intestinal peptide upon inhibition of gastric acid secretion by duodenal acid and hyperosmolal solutions in the conscious ratC Wallin, G Grupcev, S Emås, et al.
Diseases of the Colon and Rectum|May 1, 1984
Villous dysplasia. An ominous histologic sign in colitic patientsC A Rubio, C Johansson, P Slezak, et al.
Diseases of the Colon and Rectum|September 1, 1984
The significance of DNA distribution pattern in rectal carcinoma. A preliminary studyG Forsslund, B Cedermark, U Ohman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1984
High dose rDNA human alpha 2 interferon therapy in patients with advanced colorectal adenocarcinoma: a phase II studyG Lundell, H Blomgren, B Cedermark, et al.
Pageof 63